BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37522333)

  • 1. Expertise as a Response to Limited Multilateralism: The Case of South Korea's Vaccine Procurement Task Force for COVID-19 Vaccines amid Unequal Access via the COVAX Facility.
    Park J
    J Health Polit Policy Law; 2024 Feb; 49(1):99-132. PubMed ID: 37522333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six Pivotal Lessons Learned in South Korea for Whole-of-Government Approach to Successful COVID-19 Vaccine Rollout in Planetary Health.
    Hong SA
    OMICS; 2022 Oct; 26(10):567-579. PubMed ID: 36112347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic assessment of South Korea's capabilities to control COVID-19.
    Yoo KJ; Kwon S; Choi Y; Bishai DM
    Health Policy; 2021 May; 125(5):568-576. PubMed ID: 33692005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigating donor interests in the case of COVID-19 vaccine: the implication of COVAX and DAC membership.
    Fang Y; Ma T; Wu M; Tsuei SH
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36642442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
    Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. South Korea's low fertility raises European-style issues.
    Haub C
    Popul Today; 1991 Oct; 19(10):3. PubMed ID: 12284303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccination program in South Korea: A long journey toward a new normal.
    Kwon SL; Oh J
    Health Policy Technol; 2022 Jun; 11(2):100601. PubMed ID: 35127400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New framework to assess tracing and testing based on South Korea's response to COVID-19.
    Kim J; Jo S; Cho SI
    BMC Infect Dis; 2024 May; 24(1):469. PubMed ID: 38702610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 14. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why does the COVAX facility fail to bridge the 'immunization gap'?
    Shao Q
    J Public Health Policy; 2024 Mar; 45(1):126-136. PubMed ID: 38243069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European collaborations on medicine and vaccine procurement.
    Vogler S; Haasis MA; van den Ham R; Humbert T; Garner S; Suleman F
    Bull World Health Organ; 2021 Oct; 99(10):715-721. PubMed ID: 34621089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
    Fajber K
    Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the policy dynamics of COVID-19 vaccination in Ghana through the lens of a policy analytical framework.
    Atinga RA; Koduah A; Abiiro GA
    Health Res Policy Syst; 2022 Sep; 20(1):94. PubMed ID: 36050739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.